Related by context. All words. (Click for frequent words.) 67 transplanted islets 65 immunosuppressive medications 65 corticosteroid therapy 64 immune suppressing 64 H. pylori eradication 64 aromatase inhibitor therapy 64 immunosuppressant medications 63 autologous transplants 63 immunosuppressant drugs 63 immune suppressants 63 CMV infections 63 immunosuppression 63 androgen deprivation 62 statins cholesterol lowering 62 immunosuppressive drugs 62 cisplatin chemotherapy 62 surgical debulking 62 trastuzumab Herceptin ® 62 tamoxifen therapy 62 antireflux surgery 62 interferon therapy 62 allogeneic HSCT 62 Liver transplantation 62 Gleevec imatinib 62 cranial radiation 62 antithrombotic therapy 62 dyskeratosis congenita 62 thiopurine 62 immunosuppressive regimens 62 EXJADE 62 erlotinib Tarceva 61 immunosuppressant medication 61 riociguat 61 adjuvant radiation 61 imatinib therapy 61 immuno suppressive drugs 61 immunosuppressive regimen 61 curative resection 61 Torisel 61 CMV disease 61 efalizumab 61 immune suppressing medication 61 immunosuppressive therapies 61 transplantation HCT 61 autologous transplant 61 IDH mutations 61 myeloablative 61 autologous hematopoietic stem cell 61 anti CD3 antibody 61 immune suppression 61 systemic immunosuppressive 61 BYSTOLIC 61 calcineurin inhibitor 61 taxane chemotherapy 61 mycophenolate 61 acute GvHD 61 basiliximab 61 DHEA supplementation 60 Chronic pancreatitis 60 thrombotic complications 60 cranial irradiation 60 intestinal polyps 60 intravenous bisphosphonates 60 androgen ablation 60 TNF antagonist 60 EGFRIs 60 concurrent chemoradiation 60 chemopreventive agent 60 K ras mutations 60 anthracycline therapy 60 adjuvant radiotherapy 60 pamidronate 60 Oral corticosteroids 60 diabetic kidney 60 retransplantation 60 TTF Therapy 60 cytoreduction 60 warfarin therapy 60 transplanted liver 60 liver scarring 60 EBV infection 60 radioiodine therapy 60 immunosuppressant 60 immunomodulatory therapy 60 hepatic toxicity 60 interstitial pneumonitis 60 systemic corticosteroid 60 LCMV infection 60 beta blocker therapy 60 immunosuppressant therapy 60 renal allograft 60 immunosuppression therapy 60 type 1diabetes 60 immunosuppressive therapy 60 lenalidomide dexamethasone 60 PTLD 60 bisphosphonate therapy 60 immunosuppressant drug 60 oral clodronate 60 orchiectomy 60 lichen planus 60 allogeneic transplant 60 HSCT 60 COREG 60 Alequel 60 Hydroxyurea 60 polyp recurrence 60 transfusion syndrome 60 immune suppressant 59 5q deletion 59 curative therapy 59 β blockers 59 anticlotting drugs 59 perioperatively 59 thromboembolic disease 59 Fingolimod 59 hydroxychloroquine 59 mutated K ras 59 Revlimid lenalidomide 59 chronic granulomatous disease 59 Naive Patients 59 recurrent infections 59 extrapleural pneumonectomy 59 Candida infection 59 SHANK3 59 Advagraf 59 R0 resection 59 testosterone supplementation 59 immunodeficient 59 immuno suppressant drugs 59 NSAID therapy 59 gemcitabine Gemzar 59 anakinra 59 Zenapax 59 mycophenolate mofetil 59 systemic toxicity 59 relapsed MM 59 methotrexate therapy 59 renoprotective 59 autologous transplantation 59 Immunosuppressive drugs 59 postoperative chemotherapy 59 colorectal cancer liver metastases 59 weekly subcutaneous injections 59 dopaminergic therapy 59 levodopa therapy 59 multiorgan 59 mutated KRAS 59 induce remission 59 Cabazitaxel 59 immune reconstitution 59 C1 INH deficiency 59 preoperative chemotherapy 59 LYSTEDA 59 HUCB cells 59 bowel resection 59 primary hyperparathyroidism 59 Sunitinib 59 antimicrobial prophylaxis 59 Ribavirin causes 59 gastrointestinal stromal tumors GIST 59 donor marrow 59 undergoing peritoneal dialysis 59 teplizumab 59 immunosuppressants 59 allogeneic SCT 59 intensive statin therapy 59 RAS blockers 59 artery stenosis 59 intravenous immunoglobulin 59 intrathecal chemotherapy 59 axonal damage 59 CTAP# Capsules 59 Adjuvant chemotherapy 59 Hurthle cell 59 cediranib 59 unresectable tumors 59 bone marrow biopsies 58 transgenic rats 58 perioperative morbidity 58 endostatin 58 cystic lesions 58 TNF alpha antagonist 58 AGILECT R 58 alefacept 58 antioxidant supplementation 58 metastatic malignant 58 NATRECOR ® 58 mTOR inhibition 58 Gleevec resistant 58 allogeneic hematopoietic stem cell 58 tumor recurrence 58 VCUG 58 BRAF mutation 58 neutropenic patients 58 CD8 + cytotoxic 58 pyrazinamide 58 relapsed ALL 58 potassium sparing diuretics 58 TroVax ® 58 chronic thromboembolic pulmonary 58 Calorie restriction 58 Natalizumab 58 metastatic kidney 58 ovarian hormones 58 debulking surgery 58 cell transplantation 58 muraglitazar 58 relapsed AML 58 torsade de pointes 58 catheter angiography 58 Surgical resection 58 anthracycline chemotherapy 58 EGFR inhibitors 58 posttransplant 58 thymic carcinoma 58 flutamide 58 HAART regimen 58 secondary amenorrhea 58 renal transplantation 58 dexrazoxane 58 curative treatments 58 #beta HSD1 58 lymph node dissection 58 idarubicin 58 humanised monoclonal antibody 58 receiving immunosuppressive therapy 58 ovariectomy 58 Nexavar sorafenib 58 anthracycline taxane 58 decitabine 58 steroid dexamethasone 58 corneal graft 58 penicillin allergy 58 Dasatinib 58 paclitaxel Taxol R 58 lenalidomide Revlimid R 58 alteplase 58 HLA matched 58 endometrial hyperplasia 58 ZOMETA 58 leukaemic stem cells 58 FASLODEX 58 adrenal suppression 58 Kinoid 58 motesanib 58 intensive lipid lowering 58 antiepileptic medications 58 cytoreductive surgery 58 chlamydial 58 immuno suppression 58 hepatectomy 58 cerebral vasospasm 58 stem cell transplantations 58 alpha blocker 58 thoracoscopic lobectomy 58 nephrotoxicity 58 undergoing radical prostatectomy 58 antifibrinolytic 58 antitumor effect 58 rBChE 58 HAART regimens 58 adriamycin 58 GnRH agonists 58 breast endometrial 58 NAbs 58 bevacizumab Avastin 58 solid organ transplantation 58 Dacogen decitabine 58 gastroesophageal junction 58 familial hypercholesterolemia FH 58 ELACYT 58 rhTSH 58 transplanted tissue 58 primidone 58 nonischemic 58 hMG 58 suppressive therapy 58 cytotoxic effects 58 selegiline 58 basal cell nevus syndrome 58 therapeutic regimens 58 Fanconi syndrome 58 Vandetanib 58 mTOR inhibitors 58 gastric adenocarcinoma 58 TTR gene 58 herpes zoster vaccine 58 TKI therapy 57 undergoing hysterectomy 57 standard chemotherapy regimens 57 fulvestrant 57 probiotic supplementation 57 refractory Hodgkin 57 complete cytogenetic response 57 intravenous immunoglobulin IVIg 57 MAGE A3 ASCI 57 MyVax R 57 Revimmune 57 Doxil ® 57 ADPKD 57 peritoneal carcinomatosis 57 symptom flare ups 57 Cytoxan 57 acute humoral rejection 57 Cellcept 57 vitamin B# folic acid 57 antidepressant therapy 57 pancytopenia 57 Ataluren 57 liver metastasis 57 temsirolimus 57 Teriflunomide 57 tafamidis 57 idiopathic thrombocytopenic purpura ITP 57 androgen suppression therapy 57 thyroid hormone replacement 57 hematologic abnormalities 57 sitaxsentan 57 adalimumab Humira 57 arteritis 57 HBV vaccine 57 ADAMTS# 57 intra arterial chemotherapy 57 adrenal function 57 docetaxel chemotherapy 57 induce regression 57 Riluzole 57 GIST tumors 57 squalamine 57 standard chemotherapy regimen 57 antihypertensive therapy 57 inhibit platelet function 57 Mitoxantrone 57 thromboprophylaxis 57 Azathioprine 57 precancerous condition 57 gastrointestinal stromal tumor 57 hyperphenylalaninemia HPA due 57 Bone marrow transplant 57 allogeneic transplantation 57 postoperative morbidity 57 Simulect 57 bevacizumab Avastin ® 57 Diamyd r 57 postoperative radiotherapy 57 lung metastasis 57 antirejection drugs 57 Genetic predisposition 57 infliximab 57 LHRH agonists 57 cilostazol 57 thalidomide Thalomid 57 liver biopsies 57 severe neutropenia 57 myeloproliferative disease 57 intensity allogeneic stem 57 CMV infection 57 Myfortic 57 PROCHYMAL 57 renal flares 57 fluvastatin 57 Inhaled nitric oxide 57 Gleevec imatinib mesylate 57 levodopa carbidopa 57 antifungal therapy 57 LNG IUS 57 TBC# 57 colon tumors 57 membranous nephropathy 57 renal transplants 57 antitumor efficacy 57 procalcitonin 57 cytotoxic chemotherapy 57 recurrent glioblastoma multiforme 57 cervical lymph nodes 57 postoperative atrial fibrillation 57 GRNCM1 57 metastatic lung cancer 57 Dose escalation 57 Tolamba 57 rituximab Rituxan 57 lumiliximab 57 anti androgen 57 aprepitant 57 antidiabetic therapy 57 Malignant tumors 57 impair fertility 57 tranylcypromine 57 TYSABRI natalizumab 57 Vidaza azacitidine 57 Eisenmenger syndrome 57 Ebola SNALP 57 prostate adenocarcinoma 57 Tolvaptan 57 Gleevac 57 MMP inhibitors 57 ProSavin 57 ovarian hyperstimulation syndrome 57 IFN beta 57 chronic renal disease 57 Vincristine 57 allogeneic stem cell 57 immunopathology 57 oxaliplatin Eloxatin 57 pancreatic islet 57 gastrointestinal stromal tumors GISTs 57 metastatic bladder 57 SNT MC# 57 IVIG therapy 57 renal toxicity 57 protease inhibitor PI 57 oral anticoagulant therapy 57 preterm newborns 57 invasive candidiasis 57 ZOLINZA 57 Zoledronic acid 57 endometrial carcinoma 57 pre malignant lesions 57 Islet transplantation 57 chemo radiotherapy 57 sorafenib Nexavar 57 selenium supplementation 57 Mycograb 57 invasive fungal infection 57 Delayed Graft Function 57 goserelin 57 immunological responses 57 glucocorticoid therapy 57 anticoagulants blood thinners 57 nitrofurantoin 57 allogeneic transplants 57 immunomodulatory therapies 57 antiinflammatory drugs 57 abatacept 57 enucleation 57 recurrent glioblastoma 57 hypercalcemia 57 mapatumumab 57 concomitant medications 57 biliary obstruction 57 antibiotic prophylaxis 57 hormone refractory 57 decompressive surgery 57 visilizumab 57 hypocalcaemia 57 malignant transformation 57 FUSILEV enhances 57 SGS# 57 iron chelation therapy 57 pegylated liposomal doxorubicin 57 ovulatory cycles 57 bilateral oophorectomy 56 EGFR TKI 56 forodesine 56 immuno therapy 56 LHRH analogues 56 Trovax 56 liver decompensation 56 systemic amyloidosis 56 PROSTVAC VF 56 gemifloxacin 56 chemoradiotherapy 56 porcine islets 56 Tacrolimus 56 thalidomide dexamethasone 56 metaplasia 56 neuroblastoma tumors 56 cholinesterase inhibitor 56 HNSCC 56 sunitinib Sutent 56 smoldering multiple myeloma 56 allogeneic hematopoietic cell 56 cancerous colon polyps 56 Sutent sunitinib 56 pancreatic adenocarcinoma 56 ovarian suppression 56 flavopiridol 56 Ocrelizumab 56 cytopenia 56 Nilotinib 56 colorectal carcinoma 56 rHuEPO 56 deletion 5q 56 aldosterone antagonists 56 Cell Lymphoma CTCL 56 corifollitropin alfa 56 chronic eosinophilic leukemia 56 lung fibrosis 56 taxane therapy 56 Mitomycin C 56 Taxol paclitaxel 56 thromboembolic complications 56 CellCept mycophenolate mofetil 56 Luveris 56 TNFa 56 canakinumab 56 hyperparathyroidism 56 posaconazole 56 uterine fibroid 56 JAK3 56 vandetanib 56 Prostatitis 56 postoperative ileus 56 dexanabinol 56 protamine 56 gastrointestinal toxicity 56 prostate cancer CRPC 56 cisplatin gemcitabine 56 adrenalectomy 56 infliximab Remicade 56 MS relapses 56 candidemia 56 adiponectin levels 56 pelvic lymphadenectomy 56 vecuronium 56 overlapping toxicities 56 phase IIb trial 56 cerebral angiography 56 VAPRISOL 56 pretransplant 56 metastatic malignant melanoma 56 rFVIIa 56 BoNTA 56 nephrotoxic drugs 56 L dopa 56 cytotoxic therapy 56 pituitary hormone 56 PSMA ADC 56 bone marrow suppression 56 Lung transplantation 56 Caprospinol 56 Certolizumab pegol 56 HbF 56 Duodenal 56 Hashimoto thyroiditis 56 vasodilators 56 Nesiritide 56 hematopoietic cell 56 Velcade bortezomib 56 pharmacokinetic interactions 56 Kepivance 56 antiarrhythmic drugs 56 gadobutrol 56 transplantation HSCT 56 postmenopausal estrogen 56 PRADAXA 56 glioblastoma tumors 56 Cetuximab 56 oocyte retrieval 56 paroxetine Paxil 56 HIV HCV coinfected 56 radiochemotherapy 56 OHR/AVR# 56 paroxysmal AF 56 olmesartan 56 recurrent metastatic 56 ALND 56 Pulminiq 56 Panzem 56 brain lesions 56 ACV1 56 beta lactam antibiotic 56 mitoxantrone plus 56 pancreatitis inflammation 56 psoriatic arthritis PsA 56 eculizumab therapy 56 androgen suppression 56 opioid analgesia 56 investigational monoclonal antibody 56 maximally tolerated lipid lowering 56 GnRH agonist 56 blood clot dissolving 56 bypass grafting 56 cystic fibrosis chronic pancreatitis 56 suppress viral replication 56 lapatinib Tykerb 56 reimplantation 56 hypervascular tumors 56 pharmacologic intervention 56 thyrotoxicosis 56 ixabepilone 56 ganciclovir 56 allograft rejection 56 idraparinux 56 hepatic metastases 56 Valproate 56 atacicept 56 thrombophilia 56 paclitaxel poliglumex 56 anticoagulation therapy 56 fibroma 56 sonographic diagnosis 56 CYP #A# 56 Menopausal hormone therapy 56 TMP SMX 56 relapsed SCLC 56 AV grafts 56 leflunomide 56 nonpharmacologic 56 leukoreduction 56 vidofludimus 56 gefitinib Iressa 56 antiarrhythmic medications 56 belatacept 56 IGFBP 3 56 Severe Primary IGFD 56 untreated celiac disease 56 pouchitis 56 kidney pancreas transplant 56 inhaled glucocorticoids 56 imipenem 56 Herceptin trastuzumab 56 MyVax 56 sulfonylurea metformin 56 DMARDS 56 stimulate ovulation 56 folinic acid 56 chronic GVHD 56 immunologically matched 56 immunological rejection 56 peginterferon 56 immune modulating 56 chromium supplementation 56 DFMO 56 MGd 56 interstitial nephritis 56 GVAX 56 Lupus nephritis 56 dopamine antagonists 56 antiviral therapy 56 Vorapaxar 56 imatinib resistance 56 Aprotinin 56 AMEVIVE 56 apneic episodes 56 Allogeneic 56 relapsing remitting MS RRMS 56 Eltrombopag 56 relapsing MS 56 renal biopsy 56 radiation therapy SBRT 56 persistent pulmonary hypertension 56 reperfusion injury 56 postoperative complication 56 neurological degeneration 56 Tavocept 56 Bezielle 56 ATACAND 56 neurodevelopmental outcomes 56 Didanosine 56 iron chelation 56 autoimmune reactions 56 Belatacept 56 immunocompetent 56 Anthracycline 56 squamous cell lung cancer 56 Arikace 56 Teriparatide 56 meniscectomy 56 malabsorptive 56 menadione 56 olaparib 56 relapsed ovarian cancer 56 cancerous polyp 56 pentoxifylline 56 XmAb# 56 serum calcium levels 56 cells MSCs 56 cardiac toxicity 56 renal kidney 56 Pegylated Interferon 56 beta adrenergic receptor 56 immuno suppressants 56 iniparib 56 Alessandro Riva 56 myopathy rhabdomyolysis 56 gemcitabine chemotherapy 56 chemotherapy cisplatin 56 edifoligide 56 antithymocyte globulin 56 pulmonary toxicity 56 antiangiogenic agents 56 oral antidiabetic medication 56 ventricular remodeling 56 Epstein Barr virus EBV 56 bevacizumab Avastin Genentech 56 durable remissions 56 Adjuvant therapy 56 combination antiretroviral therapy 56 Radical prostatectomy 56 liver metastases 56 KETEK 56 esophagectomy 55 velafermin 55 acid suppressive drugs 55 SOD1 gene 55 alkylating agent 55 SCIg 55 APTIVUS r 55 BMPR2 55 nephrectomy 55 ethosuximide 55 p# activation 55 haematopoietic 55 Crizotinib 55 BEXXAR therapeutic regimen 55 antibiotic regimens 55 pancreatic tissue 55 INGAP 55 insulin secreting cells 55 prednisone steroid 55 endocrine therapies 55 BEXXAR Therapeutic Regimen 55 thrombocytosis 55 Postoperative complications 55 peritoneal cancer 55 atopic disease 55 Heavy menstrual bleeding 55 thienopyridine 55 tipifarnib 55 KRAS status 55 intra abdominal abscess 55 Tarceva erlotinib 55 antiproliferative effects 55 operable breast cancer 55 neuroinflammatory diseases 55 MYCN amplification 55 viral reactivation 55 vaginal hysterectomy 55 symptomatic hyponatremia 55 mesalamine granules 55 HuMax CD4 55 Cinquil 55 percutaneous cryoablation 55 hematological toxicity 55 midstage trials 55 pCR 55 vasospasm 55 portal vein thrombosis 55 neoplastic cells 55 Lisofylline 55 PARP inhibition 55 Pulmonary hypertension 55 adenomatous polyps 55 Relapsing remitting MS 55 decompensated heart failure 55 neurologic progression 55 Ophena 55 azacitidine 55 cellular immunotherapy 55 potentiation 55 inhibit metastasis 55 ovarian hyperstimulation syndrome OHSS 55 nonalcoholic steatohepatitis NASH 55 amenorrhoea 55 adjuvant cisplatin 55 MYCAMINE 55 Mepact 55 HERCEPTIN 55 gastrointestinal stromal tumor GIST 55 minimally symptomatic 55 carotid artery blockage 55 samalizumab 55 heterozygous FH 55 Combination therapy 55 Allovectin 7 ® 55 severe hypersensitivity reactions 55 adalimumab 55 TNF alpha inhibitor 55 postoperative bleeding 55 letrozole Femara 55 antiplatelet medication 55 ritonavir boosted lopinavir 55 fibrate drugs 55 Hypotension 55 Vacc 4x 55 calcineurin inhibitors 55 pimozide 55 nitazoxanide 55 adefovir 55 chlamydial infection 55 imatinib 55 T1DM 55 pheochromocytoma 55 resynchronization therapy 55 IRX 2 55 pentosan 55 coagulation abnormalities 55 de novo kidney transplant 55 Cremophor 55 lipid lowering therapy 55 enzastaurin 55 HIV lipodystrophy 55 Graft Versus Host 55 CIMZIA TM 55 MYLOTARG 55 CTEPH 55 systemic hypotension 55 pneumonectomy 55 endoscopic resection 55 homozygous familial hypercholesterolemia 55 parkinsonian symptoms 55 Azacitidine 55 atypical hemolytic uremic syndrome 55 nonsurgical treatments 55 statin medications 55 vestibular schwannomas 55 intradermal injection 55 metastatic neuroendocrine tumors 55 imexon 55 Cholangiocarcinoma 55 reinnervation 55 pulmonary artery banding 55 clinically detectable 55 acute promyelocytic leukemia 55 hemodilution 55 CsA 55 efavirenz Sustiva 55 ImmuKnow 55 hypersensitivity reaction 55 renal fibrosis 55 adrenocortical cancer 55 adenotonsillectomy 55 talabostat 55 Sorafenib 55 neoadjuvant treatment 55 recombinant erythropoietin 55 antigen PSA 55 Torisel temsirolimus 55 proliferative retinopathy 55 danazol 55 imatinib Gleevec 55 sunitinib 55 immunosuppressive agents 55 Dapagliflozin 55 flecainide 55 biochemical relapse 55 postoperative mortality 55 BRAF V#E mutation 55 cetuximab Erbitux 55 Cyclosporine 55 hypoperfusion 55 defibrillator implant 55 pancreatic endocrine 55 perioperative complications 55 Motavizumab 55 immunological tolerance 55 hormonal stimulation 55 Decitabine 55 CYPHER Stent 55 Infliximab 55 skeletal metastases 55 Fibrillex TM 55 mucosal healing 55 colectomy 55 TAXOTERE ® 55 leukoencephalopathy 55 neoadjuvant therapy 55 dexamethasone Decadron 55 FOLFOX6 55 ICD therapy 55 hereditary predisposition 55 parathyroid carcinoma 55 graft dysfunction 55 Caloric restriction 55 treprostinil 55 myocardial ischemia 55 dermatologic reactions 55 neurotrophic 55 hematological parameters 55 myelodysplastic myeloproliferative diseases 55 lung resection 55 Estrogens 55 leukemia ALL 55 Leydig cell 55 bicalutamide 55 Traficet EN 55 urate levels 55 underlying pathophysiology 55 Symadex 55 haematologic 55 decompensated cirrhosis 55 liver transplant recipients 55 neurodevelopmental outcome 55 thymectomy 55 thrombocytopenic 55 nadolol 55 KOMBIGLYZE XR 55 serum phosphate levels 55 nerve degeneration 55 tibolone 55 malignant neoplasm 55 parasitemia 55 acute mania 55 allogeneic bone marrow 55 salivary function 55 HBV vaccination 55 ribavirin therapy 55 antiangiogenic therapy 55 cardiotoxic 55 Diamyd ® 55 bacterial prostatitis 55 Uricase PEG 55 intravesical therapy 55 aldosterone antagonist 55 peg interferon 55 potentially hepatotoxic 55 angiotensin receptor blockers ARBs 55 pancreatectomy 55 histologic subtype 55 obstructive coronary 55 Xelox 55 gastric distention 55 biliary tract cancer 55 HIPEC 55 colorectal adenoma 55 systemic mastocytosis 55 reinfarction 55 noninfectious uveitis 55 PRT# 55 renal parenchyma 55 BENICAR HCT 55 induced anemia 55 antiresorptive 55 hematopoietic cancers 55 hematologic parameters 55 clodronate 55 CYT# potent vascular disrupting 55 mg kg dose 55 hepatorenal syndrome 55 TransVax 55 Aggrastat ® tirofiban hydrochloride 55 serologic testing 55 Cimzia TM 55 systemic scleroderma 55 trastuzumab Herceptin 55 severe dermatologic toxicities 55 vWF 55 revascularizations 55 metastatic castration resistant 55 MitraClip device 55 palifermin 55 receiving XGEVA 55 #F FDG PET 55 RhuDex 55 Paliperidone 55 nonalcoholic steatohepatitis 55 antitumor effects 55 paclitaxel cisplatin 55 synthetic progestin 55 mepolizumab 55 5-fluorouracil/leucovorin 55 metastatic RCC 55 non ulcer dyspepsia 55 cilengitide 55 amoxicillin clavulanate 55 endometrial biopsy 55 lymph node removal 55 virologic failure 55 NATRECOR R 55 radical cystectomy 55 cidofovir 55 bortezomib Velcade 55 Cytarabine 55 Imatinib 55 VA# [002] 55 indolent follicular non 55 parathyroidectomy 55 mixed hyperlipidemia 55 intravenous diuretics 55 weekly intravenous infusions 55 Pseudomonas aeruginosa infections 55 islet transplants 55 antiplatelet therapy 55 lysosomal storage disease 55 invasive diagnostic 55 extrapyramidal symptoms EPS 55 antimetabolite 55 SSc 55 pulmonary metastasis 55 uterus womb 55 invasive aspergillosis 55 hormonal therapies 55 mycophenolate mofetil MMF 55 pemetrexed Alimta 55 anticancer therapy 55 dose cyclophosphamide 55 transplanted organ 55 myoblast therapy 55 Sprycel dasatinib 55 immuno suppressive 55 RAS mutations 55 sevelamer 55 BH4 55 HBV infection 55 salmeterol fluticasone 55 severe asthma exacerbations 55 recurrent UTI